Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial
-
- STATUS
- Recruiting
-
- days left to enroll
- 33
-
- participants needed
- 750
-
- sponsor
- The TIMI Study Group
Summary
This is a multicenter, open-label, 2x2 factorial, randomized-controlled trial in critically-ill patients with novel coronavirus disease 2019 (COVID-19) evaluating the efficacy and safety of full-dose vs. standard prophylactic dose anticoagulation and of antiplatelet vs. no antiplatelet therapy for prevention of venous and arterial thrombotic events.
Details
| Condition | Venous Thromboembolism, Thromboembolism, Arterial Thrombosis, *COVID-19, Covid-19 |
|---|---|
| Treatment | Clopidogrel, Enoxaparin 40 Mg/0.4 mL Injectable Solution, Unfractionated Heparin IV, Enoxaparin 1 mg/kg, Unfractionated heparin SC |
| Clinical Study Identifier | NCT04409834 |
| Sponsor | The TIMI Study Group |
| Last Modified on | 24 January 2021 |
Eligibility
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer